First 35 dogs complete baseline cognitive assessments in TRIAD rapamycin trial

Dog Aging Project/TRIAD (Test of Rapamycin in Aging Dogs)

The initial cohort of 35 dogs in the TRIAD trial underwent comprehensive baseline assessments including cognitive function evaluations and health markers. These early participants form the foundation for measuring how rapamycin affects aging in companion animals.